हाल में देखा गया

  • होम
  • स्टोरी
  • News Announcement
  • Parmax Pharma: Receipt Of ''In-Principle'' Approval Under Regulation 28(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issuance Of Equity Shares And Warrants On Preferential Basis
News Announcement

Parmax Pharma: Receipt Of ''In-Principle'' Approval Under Regulation 28(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Issuance Of Equity Shares And Warrants On Preferential Basis

22-अगस्त-2026 Follow Value Research Online on Google download pdfडाउनलोड पीडीएफ़ Parmax Pharma

Receipt of In Principle Approval

वैल्यू रिसर्च से पूछें aks value research information

कोई सवाल छोटा नहीं होता. पर्सनल फ़ाइनांस, म्यूचुअल फ़ंड्स, या फिर स्टॉक्स पर बेझिझक अपने सवाल पूछिए, और हम आसान भाषा में आपको जवाब देंगे.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan